ALZN Alzamend Neuro Inc
Company Analysis
Latest News
🔴 Alzamend Neuro is trading 5.6% down on October 22, 2026 amid broad market weakness
Alzamend Neuro is trading at $1.18, down -5.60%, amid broad market weakness. - No October 22 company-specific announcement explaining the decline appeared in...
🟢 Alzamend Neuro is trading 7.75% up today with no verified company-specific catalyst
Alzamend Neuro is trading at $1.39, up 7.75%, on October 21, 2026; no verified company-specific announcement explaining the move was found. - XBI was reported...
🟢 Alzamend Neuro is trading 9.3% up in after-hours trading — with no verified company-specific catalyst identified
Alzamend Neuro is trading 9.28% higher at $1.41 after closing at $1.30 on October 20; no verified company-specific announcement explaining the after-hours move...
🟢 Alzamend Neuro is trading 12% up in pre-market with no verified company-specific catalyst
Alzamend Neuro is trading at $1.49, up 12.03%, in pre-market; no verified company-specific announcement explaining the move was found. - Company news listings...
🟢 Alzamend Neuro is trading 6% up; catalyst unclear
Alzamend Neuro is trading at $1.33, up 5.95%, with the reason for the October 16 rise unclear. - No verified company-specific announcement explaining the move...
🟢 Alzamend Neuro is trading 5.6% up in after-hours trading with no verified company-specific catalyst
Alzamend Neuro is trading at $1.33, up 5.56% in after-hours trading, with no verified company-specific announcement dated October 15 explaining the move. - It...
🟢 Alzamend Neuro is trading 9.1% up
Alzamend Neuro is trading at $1.43, up 9.13%, with no new company announcement or clearly reported catalyst identified for October 13. - The company’s latest...
🟢 Alzamend Neuro is trading 17% up in pre-market; no clear catalyst identified
Alzamend Neuro is trading 17.04% higher at $1.58, with no clear October 12 catalyst identified. - That compares with the October 9 close of $1.34. - A Zacks...
🟢 Alzamend Neuro is trading 6.7% up with no confirmed catalyst
Alzamend Neuro is trading at $1.43, up 6.72%, with no confirmed catalyst identified. - No new company announcement was identified for October 9; the latest...
🟢 Alzamend Neuro is trading 7.46% up in pre-market
Alzamend Neuro is trading 7.46% higher at $1.44 in pre-market, with no new company announcement identified to explain the October 9 move. - The company’s...
🔴 Alzamend Neuro is trading 10.9% down amid biotech-sector weakness
Alzamend Neuro is trading at $1.23, down 10.87%, with sector pressure a possible contributor; no specific catalyst is confirmed. - No Alzamend Neuro...
🟢 Alzamend Neuro is trading 8% up today with broader-market gains possibly offering support
Alzamend Neuro is trading at $1.48, up 8.03%; broader market gains may be contributing, but no direct link to the move is established. - U.S. stocks and...
🔴 Alzamend Neuro is trading 6% down in pre-market amid secondary report of AL001 dosing
Alzamend Neuro is trading 6.02% down at $1.29 in pre-market on October 5, alongside secondary coverage reporting AL001 trial dosing. - The October 5 report...
🟢 Alzamend Neuro is trading 10.5% up with no clear company-specific catalyst identified
Alzamend Neuro is trading at $1.47, up 10.53%, with no clear company-specific catalyst identified. - It closed at $1.31 on October 1; its latest official...
🟢 Alzamend Neuro is trading 9% up with no clear catalyst identified
Alzamend Neuro is trading 9.02% higher at $1.45 on October 2; no clear company-specific catalyst has been identified. - The stock fell 23.99% to $1.31 at the...
🔴 Alzamend Neuro is trading 6% down; no clear catalyst identified
Alzamend Neuro is trading 6.02% lower at $1.25, with no clear company-specific catalyst identified. - The decline extends the sharp October 1 drop, when...
🟢 Alzamend Neuro is trading 5.7% up in pre-market with no clear company-specific catalyst identified
Alzamend Neuro is trading 5.72% up at $1.41 in pre-market on October 2, 2026, with no clear company-specific catalyst identified. - The move follows a sharp...
🟢 Alzamend Neuro is trading 18% up in after-hours trading with no clear catalyst identified
Alzamend Neuro is trading 17.77% higher at $1.57 in after-hours, with no clear company-specific catalyst identified. - It closed the October 1 regular session...
🔴 Alzamend Neuro is trading 11% down; no clear catalyst identified
Alzamend Neuro is trading 10.68% lower at $1.55, with no clear company-specific catalyst identified for the October 1, 2026 decline. - The latest company...
🔴 Alzamend Neuro is trading 6.4% down today
Alzamend Neuro is trading at $1.62, down 6.36%, with no clear cause for the decline identified in available evidence. - No company-specific announcement dated...